Middle-East and Africa Stroke Diagnosis and Treatment Market Overview
The Middle East and Africa Stroke Diagnosis and Treatment Market Size was valued at USD 0.15 Billion in 2022. The Middle East and Africa Stroke Diagnosis and Treatment market industry is projected to grow from USD 0.16 Billion in 2023 to USD 0.39 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.8% during the forecast period (2023 - 2032). The main market drivers that are anticipated to drive demand in the market during the projected period are rising disposable incomes and a rise in new product development.
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Middle-East and Africa Stroke Diagnosis and Treatment Market Trends
- Increasing high blood pressure among the population is driving the market growth
The growing spread of high blood pressure and the rise in the number of stroke diseases among individuals is driving Market CAGR for Middle-East and Africa Stroke Diagnosis and Treatment. A stroke happens in case the blood supply towards the brain is reduced or cut off entirely, depriving the brain tissue of oxygen and nutrients. For example, computed tomography (CT SCAN), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound, and others are among the diagnostic tools used to identify stroke and its early symptoms.
The demand for stroke diagnostics has increased in developing nations because of the rising prevalence of stroke, cardiovascular illness, and neurological disorders. Additionally, the increase in healthcare costs is fueling market expansion. However, the expensive cost of diagnostics can impede market expansion. An opportunity is being presented by the presence of market participants and new product launches.
The COVID-19 pandemic is expected to have had a substantial impact on the market for ischemic stroke diagnostics since the majority of medical treatments had to be postponed to stop the spread of the SARS-Cov2 virus. According to Julie Sanders' study article, which was launched in the Journal of Cardiothoracic Surgery in March 2021, the number of cardiac surgeries decreased by 50-75% during the pandemic, with a loss of 50% in the number of ICU beds and specialized cardiac theatre rooms in the UK. Additionally, according to study findings "The Effect of COVID-19 on Adult Cardiac Surgery in the United States in 717 103 Patients," which were published in the Annals of Thoracic Surgery journal in July 2021, an estimated 53% decrease in the total volume of cardiac surgery was observed in the United States in 2020 as compared to 2019, which was primarily attributed to the impact of COVID-19 pandemic. Thus, driving the Middle East and Africa Stroke Diagnosis and Treatment market revenue.
Middle-East and Africa Stroke Diagnosis and Treatment Market Segment Insights
Middle-East and Africa Stroke Diagnosis and Treatment Type Insights
The Middle East and Africa Stroke Diagnosis and Treatment market segmentation, based on the type, is divided into Ischemic strokes, Hemorrhagic strokes, and Others. Due to growing healthcare awareness, an increase in diabetes prevalence, a jump in the number of tobacco users, and an increase in the senior population, the ischemic stroke category was the largest contributor to the market and is predicted to maintain its dominance during the forecast period.
Middle-East and Africa Stroke Diagnosis and Treatment Diagnosis Insights
Based on the diagnosis of Middle-East and Africa Stroke Diagnosis and Treatment, the Middle East and Africa Stroke Diagnosis and Treatment market segmentation includes Blood tests, Computerized tomography scans, Magnetic resonance imaging, Carotid ultrasound, Cerebral angiogram, and Echocardiogram. Due to its accuracy in ischemic stroke diagnosis, Magnetic Resonance Imaging (MRI)" now leads the type segment of the Middle East and Africa stroke diagnostic and treatment market.
Middle-East and Africa Stroke Diagnosis and Treatment, Treatment Type Insights
The Middle East and Africa Stroke Diagnosis and Treatment market segmentation, based on treatment type, includes Cerebral Thrombosis, Surgical clipping, Endovascular embolization, Angioplasty & stents, and Surgical AVM removal. The market was dominated by the endovascular embolization category. Due to its accuracy in ischemic stroke diagnosis, Magnetic Resonance Imaging (MRI)" now leads the type segment of the Middle East and Africa stroke diagnostic and treatment market.
Figure 1 Middle-East and Africa Stroke Diagnosis and Treatment Market, by Treatment Type, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Middle-East and Africa Stroke Diagnosis and Treatment Regional Insights
By region, the study provides market insights into the Middle East and Africa. During the projected period, the Africa Stroke Diagnosis and Treatment market is expected to dominate over the course of the forecasted period. The improvement of the healthcare industry, rising research and development activity, and favorable government regulations are fostering regional market expansion.
Further, the major countries studied in the market report are Africa and Latin America.
Figure 2 MIDDLE-EAST AND AFRICA STROKE DIAGNOSIS AND TREATMENT MARKET SHARE BY REGION 2022 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Middle-East and Africa Stroke Diagnosis and Treatment Key Market Players & Competitive Insights
Leading market players are investing capital and resources across research and development to extend their product offerings, this is expected to help the Middle East and Africa Stroke Diagnosis and Treatment market, grow even more. Market leaders and manufacturers are also adopting various strategies to expand their worldwide footprint, with important market developments including new product developments & launches, contracts & agreements, mergers & acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Middle East and Africa Stroke Diagnosis and Treatment industry must offer cost-effective items.
The manufacturers are making use of locally available resources to minimize production costs which will aid the growth of the Middle East and Africa Stroke Diagnosis and Treatment industry to benefit clients and increase the market sector. In recent years, the Middle East and Africa Stroke Diagnosis and Treatment industry has offered some of the most significant advantages to medicine. Major players in the Middle-East and Africa Stroke Diagnosis and Treatment Market, including King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, and others, are attempting to increase market demand by investing in research and development operations.
A non-profit, multi-specialty medical organization, the Cleveland Clinic Foundation (Cleveland Clinic) offers clinical and hospital care services. It functions via a network of clinics and hospitals. The business combines its services with those of academic and research institutions. Regional hospitals, regional care centers, a children's hospital, research laboratories, and facilities for pathology and cancer, eye, heart, and urologic care are all part of Cleveland Clinic's network of institutions. Numerous specialty and sub-specialty departments at Cleveland Clinic provide services in a range of fields, including dermatology, cancer, pediatrics, pain management, ophthalmology, orthopedics, and respiratory care. It is present in Florida and Nevada in the United States, as well as in London, Abu Dhabi, and Canada. The US city of Cleveland, Ohio, is home to the Cleveland Clinic. In July 2023, Cleveland Clinic Abu Dhabi and Sheikh Shakhbout Medical City (SSMC) have been named Centres of Excellence for stroke in the Emirate by the Department of Health - Abu Dhabi (DoH), which oversees the healthcare industry in the Emirate.
One of the top hospital providers in the Middle East and the primary provider of secondary and tertiary healthcare in Qatar is Hamad Medical Corporation (HMC). HMC has given more than 40 years to giving all of its patients the safest, most efficient, and most compassionate care possible. The National Ambulance Service, home and residential care services, as well as 12 hospitals—nine specialty hospitals and three community hospitals—are all managed by HMC. In January 2016, HMC made history by becoming the first healthcare system in the world to have all of its hospitals accredited by Joint Commission International under the Academic Medical Centre accreditation program. Additionally, this esteemed accreditation has been bestowed upon the National Ambulance Service, Home Healthcare Service, Stroke Service, and Palliative Care. In    August 2021, Hamad Medical Corporation's (HMC) Stroke Service was successfully re-accredited by Joint Commission International (JCI) as the leading stroke center. Recent recognition of this outstanding accomplishment throughout the whole service spectrum occurred in April 2021 during the COVID-19 pandemic. The fact that this reaccreditation was the first of its type to be completed remotely at HMC adds to its significance.
Key Companies in the Middle East and Africa Stroke Diagnosis and Treatment market include
Middle-East and Africa Stroke Diagnosis and Treatment Industry Developments
January 2023:The innovative strategic imaging AI platform and solutions provider Blackford and the AI-powered MedTech solutions provider Brainomix have announced a strategic alliance to integrate Brainomix's comprehensive e-Stroke solution onto the Blackford Platform, enabling more institutions around the world to offer cutting-edge stroke care.
May 2021:The St. Louis-based Washington University School of Medicine and Shimadzu Corporation have signed a joint research agreement to use mass spectrometry technology in the creation of new goods. It will improve the business's R&D efforts.
Middle-East and Africa Stroke Diagnosis and Treatment Market Segmentation
Middle-East and Africa Stroke Diagnosis and Treatment Assays, Type Outlook (USD Billion, 2018-2032)
Middle-East and Africa Stroke Diagnosis and Treatment Assays, Diagnosis Outlook (USD Billion, 2018-2032)
- Blood tests
- Computerized tomography scan
- Magnetic resonance imaging
- Carotid ultrasound
- Cerebral angiogram
- Echocardiogram
Middle-East and Africa Stroke Diagnosis and Treatment Assays, Treatment Type Outlook (USD Billion, 2018-2032)
- Cerebral Thrombosis
- Surgical clipping
- Endovascular embolization
- Angioplasty & stents
- Surgical AVM removal
| Report Attribute/Metric |
Details |
| Market Size 2022 |
USD 0.15 Billion |
| Market Size 2023 |
USD 0.16 Billion |
| Market Size 2032 |
USD 0.39 Billion |
| Compound Annual Growth Rate (CAGR) |
4.8% (2023-2032) |
| Base Year |
2022 |
| Market Forecast Period |
2023-2032 |
| Historical Data |
2018- 2022 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Type, Diagnosis, Treatment Type, and Region |
| Geographies Covered |
Middle East and Africa |
| Countries Covered |
Africa and Latin America |
| Key Companies Profiled |
Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton Dickinson & Company |
| Key Market Opportunities |
Growing instances of cardiovascular diseases across the world |
| Key Market Dynamics |
Growing healthcare industry is driven by rising healthcare expenditure |
Â
Stroke Diagnosis and Treatment Market Highlights:
Frequently Asked Questions (FAQ) :
The Middle East and Africa Stroke Diagnosis and Treatment market size was valued at USD 0.15 Billion in 2022.
The market is projected to grow at a CAGR of 4.8% during the forecast period, 2023-2032.
North America had the largest share of the market
The key players in the market are Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, and Becton Dickinson & Company.
The Ischemic strokes category dominated the market in 2022.
Magnetic resonance imaging had the largest share of the market.
